Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07413068

Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis

Comparative Study of ERCP, ERCP Plus Laparoscopic Cholecystectomy, and Conservative Management in Patients With Concomitant Choledocholithiasis and Cholecystolithiasis.

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Recruit patients with cholelithiasis with concomitant choledocholithiasis into the cohort, and assign them to undergo endoscopic transpapillary gallbladder-preserving cholecystolithotomy or ERCP plus laparoscopic cholecystectomy or conservative treatment based on patient preference. Collect clinical data and patient-reported outcomes regularly at baseline and during follow-up in the cohort. Assess the clinical safety of ERCP-GPC and LC by evaluating the clinical success rate of treatment as well as the incidence of short-term and long-term postoperative complications; investigate the efficacy differences among endoscopic transpapillary gallbladder-preserving cholecystolithotomy or ERCP plus laparoscopic cholecystectomy or conservative treatment in managing cholelithiasis with concomitant choledocholithiasis.

Conditions

Interventions

TypeNameDescription
PROCEDUREendoscopic transpapillary gallbladder-preservingBased on the patient's preference, they will receive the following treatment:endoscopic transpapillary gallbladder-preserving
PROCEDUREERCP plus Laparoscopic CholecystectomyBased on the patient's preference, they will receive the following treatment:ERCP plus Laparoscopic Cholecystectomy
DRUGConservative treatmentBased on the patient's preference, they will receive the following treatment:ursodeoxycholic acid for stone dissolution,ESWL or symptomatic and supportive care.

Timeline

Start date
2025-12-01
Primary completion
2030-12-01
Completion
2030-12-01
First posted
2026-02-17
Last updated
2026-02-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07413068. Inclusion in this directory is not an endorsement.